Abstract. The ability of single subunit chimeric receptors containing various integrin fl intracellular domains to mimic and/or inhibit endogenous integrin function was examined. Chimeric receptors consisting of the extracellular and transmembrane domains of the small subunit of the human interleukin-2 receptor connected to either the fl~, f13, fl3B, or r5 intracellular domain were transiently expressed in normal human fibroblasts. When expressed at relatively low levels, the r3 and r5 chimeras mimicked endogenous ligandoccupied integrins and, like the fl~ chimera (LaFlamme, S. E., S. K. Akiyama, and K. M. Yamada. 1992. J. Cell Biol. 117:437), concentrated with endogenous integrins in focal adhesions and sites of fibronectin fibril formation. In contrast, the chimeric receptor containing the fl3s intracellular domain (a r3 intracellular domain modified by alternative splicing) was expressed diffusely on the cell surface, indicating that alternative splicing can regulate integrin receptor distribution by an intraceUular mechanism. Furthermore, when expressed at higher levels, the fl~ and r3 chimeric receptors functioned as dominant negative mutants and inhibited endogenous integrin function in localization to fibronectin fibrils, fibronectin matrix assembly, cell spreading, and cell migration. The r5 chimera was a less effective inhibitor, and the fl3B chimera and the reporter lacking an intracellular domain did not inhibit endogenous integrin function. Comparison of the relative levels of expression of the transfected fll chimera and the endogenous fl~ subunit indicated that in 10 to 15h assays, the fll chimera can inhibit cell spreading when expressed at levels approximately equal to to the endogenous/3~ subunit. Levels of chimeric receptor expression that inhibited cell spreading also inhibited cell migration, whereas lower levels were able to inhibit otsfl~ localization to fibrils and matrix assembly.
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Our results indicate that single subunit chimeric integrins can mimic and/or inhibit endogenous integrin receptor function, presumably by interacting with cytoplasmic components critical for endogenous integrin function. Our results also demonstrate that fl intracellular domains, expressed in this context, display specificity in their abilities to mimic and inhibit endogenous integrin function. Furthermore, the approach that we have used permits the analysis of intracellular domain function in the processes of cell spreading, migration and extracellular matrix assembly independent of effects due to the rest of integrin dimers. This approach should prove valuable in the further analysis of integrin intracellular domain function in these and other integrin-mediated processes requiring the interaction of integrins with cytoplasmic components.
I
NTEGRINS comprise the major class of receptors used by cells to interact with the extracellular matrix. Although some integrins are cell-type specific, most integrins are expressed in a variety of cell types, providing cells with the ability to interact with many different extracellular matrix proteins in a variety of cellular processes. Depending upon the type of cell, integrins can function in cell adhesion, mains. Recombinant subunits containing wild-type and mutant intracellular domains have been expressed in other species or in cell lines lacking the expression of the corresponding endogenous subunit in order to study the function of particular intracellular domains in the context of heterodimeric receptors. Roles have been defined in this manner for o~ intracellular domains in modulating integrin function in cell adhesion, migration, collagen gel contraction (7, 12, 37, 38), and in the regulation of affinity state of the platelet integrin, Olllb~3 (48, 49) . Requirements for/3 intracellular domain function have similarly been demonstrated for cell adhesion (29, 31), cell spreading (69), integrin localization to focal adhesions (29, 42, 62, 69), and the adhesion-dependent phosphorylation of the focal adhesion kinase pp125 FAK (27, 28, 57 ).
An alternative approach to studying integrin intracellular function is to analyze the function of integrin intracellular domains expressed as separate domains connected to an extracellular reporter and transmembrane domain. Using this approach, we and others have demonstrated that the/3t intracellular domain can function as a separate domain and can direct the localization of a reporter to focal adhesions (23, 39) , presumably by an intracellular mechanism involving an intrinsic ability of the/3~ intracellular domain to bind to cytoskeletal proteins that bind to endogenous integrins concentrated at these adhesion sites. The intrinsic ability of the /3 intracellular domain to concentrate at focal adhesions appears to be regulated in endogenous integrins by ligand occupancy in a process involving the a intracellular domain (8, 39, 69) .
These observations suggest the hypothesis that/3 intracellular domains, expressed in the absence of their corresponding ot intracellular domains, bind to similar cytoplasmic components as ligand-occupied integrins. If this hypothesis were correct, then when expressed at relatively low levels, single subunit chimeric receptors containing/3 intracellular domains should mimic endogenous integrin function, and at higher levels of expression they should inhibit endogenous integrin function by titrating out required cytoplasmic component(s). In addition, because various/3 integrin intracellular domains differ in their primary structure and these differences among integrin /3 subunits are evolutionarily conserved, individual/3 intracellular domains may differ in the functions that they can affect. We have tested this hypothesis by expressing/3 intracellular domains connected to a reporter domain and analyzing their abilities to mimic or inhibit various aspects of integrin receptor function. Using this approach, we have compared the ability of/3 intraceUular domains to direct receptor localization to focal adhesions and have defined a role for alternative splicing in regulating this process. Furthermore, we demonstrate that when expressed at relatively high levels, B chimeras can function as dominant negative mutants. Specifically, they can inhibit endogenous integrin function in cell spreading, cell migration, and extracellular matrix assembly, and they show functional specificity dependent upon the cytoplasmic domain present.
Materials and Methods

Construction of Chimeric Receptors
Chimeric receptors were constructed using standard molecular biological techniques (55) . DNAs encoding the various/3 intracellular domains were generated by the polymerase chain reaction, using PCR kits from PerkinElmer Corp. (Norwalk, CT), and were then inserted as HindIII-XhoI restriction fragments into the previously described plasmid vector encoding the control receptor, consisting of the extracellular and transmembrane domains of the intedeukln-2 (IL-2) l receptor, in place of its single intracellular lysine residue (39) . The oligonucleotide primers for the /35 intracellular domain were as follows:
The oligonucleotide primers for/33B intracellular domain were as follows: NH2-terminal primer: 5'-GGCTCACCTGGAAGCTTCTCATC-3' COOH-terminal primer: 5'-AGCGACCTCGAGTCAGAGCAATGACTTT-AGAAAAC GCCCAGC CCC GTCTCTTACTGTGTCCCATTTTGCTCT-GGC-3'.
Cells and Transfections
Normal human foreskin fibroblasts, a generous gift from Dr. Steven Alexander (Bethesda Research Laboratories, Gaithersburg, MD), were cultured in DME supplemented with 1 mM glutamine, 50 ftg/ml streptomycin, 50 U/ml penicillin, and 10% heat-inactivated FCS. Electroporation of these cells was performed as previously described (25, 26) 
Antibodies and Purified Proteins
Laminin was generously provided by Dr. Hynda Kleinman (National Institutes of Health, Bethesda, MD). Collagen I (Vitrogen 100) was purchased from Collagen Corp. (PUlo Alto, CA). Human plasma fibronectin was isolated as previously described (44 
Flow Cytometry and Fluorescence Activated Cell Sorting (FACS)
To compare the levels of expression of the various chimeras, transfected cells were harvested, washed with PBS, and incubated in a 1/100 dilution of FITC-conjngated anti-IL-2 receptor antibody 4E3 (Boehringer Mannheim Biochemicals) for 30 rain at ambient temperature, washed with PBS, fixed with 2% paraformaldehyde in PBS, and then analyzed using a Becton Dickinson FACScan flow cytometer. Similarly, to compare the level of expression of the transfected/31 chimera with the endogenous/31 subunit, cells transiently expressing the/~1 chimera were harvested, washed with PBS, divided into two aliquots, and then immunostained with either the mouse mAb 4E3 to the IL-2 receptor or the mouse mAb K20 to the/31 subunit (Amac, Inc.). After several washes in PBS, each aliquot was stained with the same FITC-labeled anti-monse second antibody, washed again with PBS, and then fixed and analyzed by flow cytometry as described above. All antibodies were determined to be at saturating concentrations.
To purify cells expressing the chimeric receptors at specific levels, transfected cells were labeled with FITC-conjugated mAb 4E3 at a 1/100 dilution in PBS containing 1% BSA. The labeled cells were sorted into low, moderate, or high expressors by FACS under sterile conditions using a Becton Dickinson FACStar Plus fluorescence-activated cell sorter and then assayed as described.
Inhibition of CeU Spreading
To compare the ability of the chimeric receptors to inhibit cell spreading on specific matrix proteins, cells were replated 15 h after transfection onto coverslips that had been previously coated with 20 /~g/ml fibronectin, vitronectin, or collagen I and blocked with 1% heat denatured BSA. After incubation for 1 h at 37°C, the cells were fixed, and then stained with mAb 7Gr/B6 to the IL-2 receptor. 10 groups of 10 randomly selected transfected and nontransfected cells were analyzed by phase contrast microscopy. The percent inhibition for each chimeric receptor on each matrix protein was calculated by subtracting the percentage of nontransfected cells that were round from the percentage of transfected cells that were round at this time. To ensure that the differences in inhibition were not due to differences in expression levels, cell surface expression was monitored by flow cytometry.
The ability of different chimeric receptors to inhibit cell spreading was also analyzed as a function of their expression level. This was accomplished by two protocols: (a) Cells were transiently transfected with the different chimeric receptors, and 15 h after transfection the cells were plated on collagen I-coated coverslips in 6-well tissue culture dishes for 1.5 h. Although the vast majority of cells from the/~3e,/~5, and control receptor transfections were attached and spread at this time, many of the cells from the/~1 and/33 transfections had not attached. To recover these unattached cells for photometric analysis, the collagen I-coated coverslips were replaced with coverslips coated with 20 ~g/ml concanavalin A followed by incubation for an additional hour at 37°C. The cells on both collagen I and concanavalin A-coated coverslips for each chimera were fixed and stained with mAb 4E3 to the IL-2 receptor. The level of expression of spread and unspread cells was determined by photometry using a photometer system (Yona Microscope & Instrument Co., Columbia, MD) based on an Oriel photomultiplier (Stratford, CT). Photometer readings from 0 to 1,400 (arbitrary units, ALl) above background were obtained for each transfection, although very few cells had readings above 600 AU. Three expression levels were defined: low, from 0--150 AU; moderate, 151-300 AU; and high, 301-600 AU. FOr each chimeric receptor, five groups of 10 randomly selected ceils within each expression level were scored for cell spreading. The percent inhibition was calculated directly with the assumption that untransfected cells were 100% spread. (b) Transiently transfected cells expressing low, moderate, or high levels of specific chimeric receptors were purified by FACS. In one experiment, cells expressing low or high levels of the B1 chimera or the control receptor were purified and then incubated on unblocked plastic tissue culture dishes in serum-containing medium. After 15 h, the ability of these cells to spread was assessed by phase contrast microscopy. In a different experiment, cells expressing low or moderate levels of either the 83 or B3a chimera were purified and then incubated in serum-containing medium. After 15 h, these cells were replated in 96-well tissue culture dishes in which the weils had been previously coated with either 20/~g/ml fibronectin or 20/~g/ml collagen I and blocked with 1% heat-denatured BSA. Cell spreading was again assessed by phase contrast microscopy. Expression levels of chimeric receptors on the sorted cells were also analyzed by photometry. The mean fluorescence of the low expressors was 122 AU which falls within the range of fluorescence defined as low (0-150 AU) by photometry and the mean fluorescence of the moderate expressers was 280 AU which falls within the range defined as moderate (151-300 AU) by photometry.
Cell Migration
Normal human fibroblasts were transfected with either the ~l chimera, the control receptor or mock transfected. 15 h after transfection, cells expressiag high levels of the transfected receptors were isolated by fluorescenceactivated cell sorting and then replated in serum-containing medium at low density (•2 x 104 cells) in 35 mm plastic tissue culture dishes (Costar Corp., Cambridge, MA), previously coated with 10/~g/ml of human plasma fibronectin. The cells were maintained in growth medium in recording chambers at 37°C supplemented with CO2. Cell migration was recorded at one frame/15 rain using either the ICM 405 or Opton inverted microscope (Carl Zeiss, Oberkochen, Germany) equipped with Newvieon Model C2400 video cameras (Hamamatsu Photonics, Hamamatsu City, Japan) as previously described (65) . For each experiment, the cells to be compared were recorded simultaneously. Images were stored on optical discs (Panasonic models TQ 2028F or TQ3031F; Matsushita Electronic Corp., Secaucus, NJ) for later analysis.
The migration rates (pm/h) of all cells that remained in the field of view for 10 h were digitized using the Track Points feature of Image 1 software (Universal Imaging Corp., West Chester, PA). A stage micrometer was used with the same microscopes, magnification, recording equipment, and monitor to standardize the scanning software to the scale of the images. Migration rates were confirmed independently by tracing the movement of individual cells on acetate sheets in direct contact with the video monitor. The tracings were then digitized with Sigma Scan software (Jandel Scientifc, Cone Madera, CA).
Inhibition of a5~z Localization to Fibronectin Fibrils and Matrix Assembly
Normal human fibroblasts were transiently transfected with the various chimeric receptors. After 24 h, the cells were replated on 22 x 22 mm cooerslips in six-well tissue culture dishes at ,~1 x 105 cells per well and then incubated an additional 15 h at 37°C. The cells were then fixed and the distribution of aSfll or fibronectin was analyzed on the cell surface of individual nonpermeabilized transfected and nontransfected cells by doublelabel immnnofluorescence using either: (a) FITC-labeled mouse mAb 4E3 to the IL-2 receptor and rat mAb 11 to the a5 subunit with a rhodaminelabeled goat anti-rat second antibody preabsorbed with mouse IgG; or (b) mouse mAb 7G7B6 to the IL-2 receptor with a rhodamine-labeled anti-mouse second antibody and FITC-labeled goat polyclonal antibodies to fibmnectin (1) . The localization of endogenous us~l was scored on individnal cells as inhibited if it was expressed diffusely on the surface of the cell. Similarly, matrix assembly was scored on individual cells as inhibited if fibronectin was not observed in fibrils or stitches on the cell surface. For each transfection, 10 groups of 10 randomly selected transfected and nontransfected cells were scored as described above. To calculate the percent inhibition, the percentage of nontransfected cells with the inhibited phenotype was subtracted from the percentage of transfected ceils with the inhibited phenotype. These experiments were repeated several times, each giving similar results. Only cells spread to similar degrees that were expressing moderate levels of the transfected chimeric receptor (as judged by phase contrast and immunofluoresconce microscopy) were analyzed. In one experiment, the level of expression of the various transfeeted chimeric receptors was monitored quantitatively by photometry to ensure that inhibition was being compared in cells expressing similar levels of the different transfected receptors. The ability of moderate levels of expression of specific chimeric receptors to inhibit matrix assembly was also determined in transfected cells purified by FACS as described below in the Results.
Results
Chimeric Receptors as Mimics of Endogenous Integrins: Localization to Focal Adhesions
Chimeric receptors (Fig. 1) were constructed containing the small subunit of the IL-2 receptor as an extracellular reporter and transmembrane domain connected to either the 83, 85, or a 83 intracellular domain modified by alternative splicing (66), designated 83s. A similar chimeric receptor containing the 81 intracellular domain was previously described (39) . To analyze and compare the ability of integrin 8 intracellular domains to direct receptor localization, nor- mal human fibroblasts were transiently transfected with the various chimeric receptors. Transfected cells were either plated on unblocked coverslips in serum-containing medium for 15 h, or on the specific matrix proteins fibronectin, collagen I, laminin, and vitronectin for 1-1.5 h. Since fibroblasts do not normally express the IL-2 receptor, the distribution of the chimeric receptors on the cell surface was analyzed by immunofluorescence using mAb 4E3 to the IL-2 receptor portion of the chimeric receptors. The presence or absence of chimeric receptors in focal adhesions was confirmed by interference reflection microscopy, where focal adhesions appear black (34) . The B3 and 8~ chimeric receptors concentrated at focal adhesions in cells cultured under all these conditions (Table  I ; Fig. 2, A and C) , indicating that the B3 and 85 intracellular domains, like the 81 intracellular domain, also contain sufficient information to target a reporter domain to focal adhesions formed by endogenous receptors. However, the 85 intracellular domain appeared to have a lesser propensity to do so compared to the/31 and/33 intracellular domains (Table I ). In contrast, the 83s chimera was expressed diffusely on the cell surface and did not concentrate in focal adhesions under any condition, indicating that the distribution of the fl3B chimera was also not affected by the identity of the substrate (Table I ; Fig. 2 B) . These results suggest that similar cytoplasmic interactions are involved in the localization of the fl~, f13, and t5 chimeras and their corresponding integrin receptors to focal adhesions. These results further suggest that alternative splicing may provide a means of regulating receptor distribution, perhaps by altering the ability of receptors to interact with the cytoskeleton. As documented previously (39), the control receptor lacking an intracellular domain was always diffuse in distribution, as was the original full-length IL-2 receptor subunit (data not shown).
Localization to Fibronectin Fibrils
When fibroblasts are plated for several hours in serumcontaining medium, their ots~, fibronectin receptors become concentrated at sites where fibronectin fibrils associate with the plasma membrane (e.g., see reference 61). The cytoskeletai proteins ot-actinin, taiin, and vinculin that are present in focal adhesions (reviewed in reference 11) can also be found colocalized with fibronectin fibrils; however, the relative amounts of these proteins and their apposition to the plasma membrane may vary (9, 10, 13, 60) . These cytoskeletal similarities suggest that perhaps the interactions between integrins and the cytoskeleton are similar at focal adhesions and sites where fibronectin fibrils associate with the plasma membrane. If this notion were correct, the/33 and/~5 intracellular domains, like the ~1 intracellular domain, should also target a reporter domain to sites of fibronectin fibril association with the plasma membrane. To explore this possibility, normal human fibroblasts were again transiently transfected with the various chimeric receptors, plated in serum-containing medium for 15 h, and then double immunostained with polyclonal antibodies to the IL-2 receptor and mAb 11 to the cq subunit of the fibronectin receptor. Colocalization of the chimeric receptor with 0t5/31 at fibronectin fibrils was scored as positive if antibodies to the IL-2 receptor colocalized with antibodies to the or5 subunit in a fibrillar pattern. We found that the/33 and/35 intracellular domains could also direct the localization of the reporter to regions where fibronectin fibrils associate with the plasma membrane since chimeric receptors containing these intracellular domains colocalized with ot5/3, at fibronectin fibrils (Fig. 3) . However, the/35 chimera appeared to have a lesser propensity to concentrate at these sites compared with the /3~ and/33 chimeras. When the localization of the/3t,/33, and /3~ chimeras was analyzed in 50 randomly selected ceils, only 17 of 50 cells expressing the /35 chimera showed colocalization of the/35 chimera with ot5/31 at fibrils; in contrast, 40/50 and 39/50 cells showed colocalization of the/3~ and/33 chimeras, respectively. Unlike the other/3 chimeras, the/33B chimera did not colocalize with ct5/31 at these sites (not shown), consistent with its inability to concentrate with endogenous integrins at focal adhesions. 
Chimeric Receptors as Dominant Negative Mutants
We next tested the possibility that high levels of expression of these chimeric receptors might function as dominant negative mutants and inhibit endogenous integrin receptor function by competing with endogenous receptors for the binding of the cytoplasmic proteins required for their function. We tested this hypothesis by analyzing the ability of various chimeric receptors to inhibit endogenous integrin receptor function in receptor localization to fibronectin fibrils, matrix assembly, cell spreading, and cell migration.
To determine the relative levels of/3 chimera available to serve as a potential dominant negative inhibitor, we first compared the level of expression of the transfected and endogenous receptors by flow cytometry as described in Materials and Methods. Transfected cells expressed the/3m chimera at levels from 1/10 that of the endogenous /3, subunit to levels 10 times higher than the endogenous subunit (Fig. 4) . Very similar results were also obtained using combinations of either mouse or rat mAbs to the IL-2 receptor and to the 31 subunit, and both types of analysis showed that over-expression of the 3t chimera does not alter cell surface expression of endogenous 3~ integrins (not shown).
Inhibition of lntegrin Receptor Function in Cell Spreading
We first tested the ability of the 3, chimera, when expressed at high levels, to function as a dominant negative mutant and inhibit endogenous integrin function in cell spreading. Normal fibroblasts were transfected with either the 3~ chimera or the control receptor lacking an intracellular domain. After 24 h, positively expressing cells were sorted by FACS into two populations: low expressors and high expressors (Fig. 5, A-F) . These different populations of sorted cells were plated separately for 15 h on unblocked tissue culture substrates in serum-containing medium. After this period of time, there was no evidence of cell surface expression of the FITC-labeled antibody originally used in the sorting protocol. Cells expressing either high or low levels of the control receptor spread and formed focal adhesions soon after plating (Fig. 5, G and H) . Although cells expressing low levels of the 31 chimera attached, spread (Fig. 5 1) ,
Figure 5. Inhibition of cell spreading in cells purified by FACS. Normal human fibroblasts expressing either low or high levels of either the control receptor (A-C) or the 3t chimera (D-F) were purified by FACS, and then an aliquot from each sample was analyzed by flow cytometry (A-F). The fraction of either low expressors (L) or high expressors (H) isolated from each transfection is indicated (A and D)
. Purified cells were then plated overnight in serum-containing medium and the ability of low (G) or high (H) expression levels of the control receptor, or low (I) or high (J) levels of the 3, chimera to inhibit cell spreading was analyzed by phase contrast microscopy (G-J). Cells expressing high levels of the 3, chimera that were incubated an additional 24 h until the level of expression of the 3t chimera decreased (K). and formed focal contacts (not shown), the majority of the high expressors remained round (Fig. 5 J) . This marked inhibition of cell spreading in high expressors was reversible. After further incubation for an additional 24 h (during which time the level of expression of the transiently transfected receptor was decreased approximately tenfold according to flow cytometry), the ceils expressing high levels of the/31 chimera that were previously inhibited in cell spreading were now able to spread (Fig. 5 K) . Similar results were also obtained when cells were transfected with the f13 chimera (not shown). High expressors were apparently not immediately lost after transfection because the transfected cells attached and formed focal adhesions prior to the cell surface expression of the transfected chimeric receptor. It is likely that the assembly of integrin transmembrane linkages is more easily inhibited than the maintenance of linkages already formed.
We then compared the ability of the/31, ~3,/35, and/~3B chimeras to inhibit cell spreading in short term assays on the specific matrix proteins, fibronectin, collagen I, and vitronectin. In this experiment, cells transiently expressing the various chimeric receptors were not purified by FACS, but were directly incubated on these substrates in serum-free medium for 1-1.5 h. The cells were then fixed and immunostained with antibodies to the IL-2 receptor, and the percentage of cells expressing each chimeric receptor that were inhibited in spreading at this time was determined as described in Materials and Methods. As quantitated in Fig. 6 , we found that expression of either the/$~ or the/$3 chimeric receptor inhibited cell spreading on all these matrix proteins, whereas the/$5 chimera was a poor inhibitor, and the/$3B chimera and the control receptor lacking an intracellular domain did not function as inhibitors of cell spreading. The intrinsic ability of cells to spread, however, was not inhibited, since cells transfected by the/$1 chimera were still able to spread if the substrate was concanavalin A (data not shown).
We next examined the relationship between the level of expression of the different chimeric receptors and their ability to inhibit endogenous function in short-term cell spreading assays on a defined substrate. Again, cells transiently expressing the various chimeric receptors were not purified by FACS but were directly incubated on collagen I for 1.5 h as described above. The cells were then immunostained using the mAb 4E3 to the IL-2 receptor and the level of expression of each chimeric receptor was analyzed in spread and nonspread cells by photometry as described in Materials and Methods. The ability of each chimeric receptor to inhibit cell spreading as a function of its level of expression is quantitated in Fig. 7 A. These results confirm our previous results and furthermore demonstrate that the/$5 chimera can also inhibit endogenous integrin function but requires higher levels of expression as compared with the/$1 and/$3 chimeras.
Differences in the abilities of low and moderate levels of expression of the/$3 and/$3B chimera to inhibit cell spreading was also demonstrated in transfected cells purified by Figure 9 . Inhibition of Cts/~ localization to fibrils and function in matrix assembly. Normal human fibroblasts were transiently transfected with the various chimeric receptors and examined for the distribution of either the t~5 subunit (.4) or fibronectin (B) on the cell surface of cells spread to similar degrees and expressing moderate levels of the chimeric receptors. The localization of cts/~ to fibrils was scored as inhibited if its expression was diffuse on the cell surface. Similarly, matrix assembly was scored as inhibited if fibronectin was not detected in fibrils or stitches on the surface of the cell. The percent inhibition was calculated as described in Materials and Methods.
FACS. These results are quantitated in Fig. 7 B and again show that the/$3B chimera does not act as an inhibitor of endogenous integrin function in cell spreading. In contrast, at low levels of expression, the/53 chimera is a poor inhibitor and at higher levels of expression effectively inhibits endogenous integrin function in cell spreading both on fibronectin and collagen I substrates.
Inhibition of CeU Migration
The ability of high levels of expression of the/$~ chimera to inhibit cell migration was also examined. Cells expressing high levels of either the/$1 chimera or the control receptor purified by FACS as in Fig. 5 were also analyzed by timelapse video microscopy. Cells expressing high levels of the control receptor were observed to spread and migrate (Fig.  8 A) , whereas cells expressing high levels of the/31 chimera remained round and did not migrate (Fig. 8 B) . Rates of cell migration were digitized, and they confirmed that expression of the chimera containing the /sin cytoplasmic domain caused a large inhibition of migration: cells expressing high levels of the control receptor lacking any cytoplasmic domain had a migration rate of 3.2 + 2.8 #m/h, whereas transfectants expressing high levels of the/$~ domain migrated at only 0.068 + 0.09 #m/h, (n = 29 and 28, respectively; P < .0001); the average migration rate was decreased by 50-fold in the presence of the/sin cytoplasmic domain. Therefore high levels of expression of the/$m chimera not only inhibited cell spreading but also cell migration.
Inhibition of ~[31 Fibronectin Receptor Localization to Fibrils and Function in Matrix Assembly
Since the 0t5/$~ fibronectin receptor has been shown to be involved in matrix assembly in culture (1, 22, 45, 53, 68, 70) , and at relatively low levels of expression, the/$~,/$3, and/$5 chimeric receptors colocalized with endogenous t~5/$~ at fibrils (Fig. 3) , we also tested the possibility that at higher levels of expression, these chimeric receptors might inhibit Figure 10 . Inhibition of matrix assembly in transfected ceils purified by FACS. Normal human fibroblasts were transiently transfected with various chimeric receptors and then were sorted into low or moderate expressors by FACS. Cells expressing either low levels of the /~ chimera (A) or moderate levels of either the B3 chimera (B), the ~3e chimera (C), or the ~5 chimera (D) were plated on coverslips in serum-containing medium for 15 h and then immunostained with FITC-conjugated polyclonal antibodies to human fibronectin. When the sorted cells expressing low and moderate levels of the transfected receptors were analyzed by photometry, the low expressors had a mean fluorescence of 122 AU and the moderate expressors had a mean fluorescence of 280 AU. Bar, 10/~m.
o~/~t localization to fibrils or matrix assembly itself. To test this possibility, normal human fibroblasts were transiently transfected with the various chimeric receptors, and 24 h later, these cells were replated on unblocked coverslips in serum-containing medium for 15 h. By double-label immunofluorescence, the distribution of ad3~ and fibronectin was determined on individual cells expressing moderate levels of the chimeric receptor. (It is important to note that while moderate levels of expression of the /3~ and /~3 chimeras inhibit cell spreading during 1-1.5 h assays, high levels of expression of these chimeric receptors are required to inhibit cell spreading in the 15 h assays used to analyze matrix assembly.) The expression of a chimeric receptor was scored as inhibiting o~5~ localization or inhibiting matrix assembly on individual cells if the distribution of or5 or fibronectin was diffuse and not concentrated in stitches or in a fibrillar pattern (see Materials and Methods). The ability of various chimeric receptors to function as inhibitors in these processes is quantitated in Fig. 9 . The ~t and/33 chimeric receptors inhibited the localization of the 0~5~ to fibrils and also inhibited fibronectin matrix assembly, although to a lesser degree. The/3s chimera, the/33B chimera and the control receptor lacking an intracellular domain showed little if any inhibition at these levels of expression. Differences in the ability of the/33, ~3~, and ~5 chimeras to inhibit matrix assembly, when expressed at moderate levels, was confirmed in transfected cells purified by FACS (Fig.  10) . Although the ~3 chimera was a poor inhibitor when expressed at low levels ( Fig. 10 A) , moderate levels of the B3 chimera did inhibit matrix assembly (Fig. 10 B) . In contrast, the/33B and ~5 chimeras were not effective inhibitors when expressed at similar levels (Fig. 10, C and D) . When randomly selected cells were analyzed for matrix assembly, only 5/50 cells expressing low levels of the/33 chimera were inhibited, whereas 34/50 cells expressing moderate levels of the/~3 chimera were inhibited. In contrast, only 1/50 and 4/50 cells expressing moderate levels of the /33B, or ~5 chimeras, respectively, were inhibited in matrix assembly.
Differences in the ability of the ~3 and/33B chimeras to inhibit us~ localization to fibronectin fibrils were also confirmed in these same ceils purified by FACS: oes/~ localization was inhibited in only 2/50 cells expressing moderate levels of the ~3B chimera, whereas 10/50 and 44/50 cells expressing low or moderate levels of the /33 chimera, respectively, had the inhibited phenotype.
Discussion
Integrin intracellnlar domains are an important link in the pathway by which cells respond to their extracellular matrix. Understanding how the extracellular matrix can affect cell behavior requires the definition and comparison of integrin intracellular domain function, as well as the determination of how this function is regulated. To this end, we have expressed various B intracellular domains as single-subunit chimeric receptors and tested the ability of these chimeras to mimic or inhibit specific aspects ofintegrin receptor function. Using this approach, we have compared the ability of different ~ intracellniar domains to direct receptor localization and have defined a role for alternative splicing in regnlat-ing this process. The ability of specific/3 chimeras to mimic the localization of ligand-occupied integrins suggested that their/3 intracellular domains can interact with cytoplasmic complexes in a ligand-independent or a constitutively "acfive" manner. If the hypothesis were correct, this ability should also allow these chimeric receptors to function as dominant negative mutants and inhibit endogenous integrin function; in fact, we found that single-subunit chimeric receptors could inhibit endogenous integrin localization and integrin functions in cell spreading, cell migration, and fibronectin matrix assembly. Furthermore, we have also demonstrated that individual/3 intracellular domains display specificity in their ability to mimic and inhibit these aspects of integrin function.
We found that the/33 and/35 chimeras, like the/3~ chimera, colocalized with endogenous integrins at focal adhesions and at sites where fibronectin fibrils associate with the plasma membrane, indicating that the/33 and/35 intracellular domains can also direct receptor localization. The ability of the/33 chimera to concentrate at focal adhesions is consistent with previous reports demonstrating the ability of endogenous/33 integrins to localize at these sites (18, 20, 61) , as well as the observation that the function of the/31 and/33 intracellular domains can be interchangeable in this process (63) . There have been, however, contrasting reports regarding the ability of endogenous/35 integrins to concentrate at focal adhesions (15, 50, 67 ; also see Stuiver, I., and J. W. Smith. 1993. Mol. Cell. Biol. 4[Suppl.] 285a). Our results with the/35 chimera are consistent with the notion that the /35 intracellular domain can also direct receptor localization to focal adhesions, but may differ in its ability to do so compared with the/3~ and/33 intracellular domains.
The ability of the/33 and/35 chimeras to colocalize with endogenous o~5/31 at sites where fibronectin fibrils associate with the plasma membrane suggests that the/33 and/35 intracellular domains, like the/3t intracellular domain, can bind to similar cytoplasmic components as as/3t at these sites, although the /35 intraceilular domain appears to have a lower affinity for these interactions. The apparent lack of colocalization of endogenous /33 and /35 integrins with /3~ integrins at fibronectin fibrils may be due to functional differences in their extraceilular domains, especially since there is no evidence as yet that any integrins other than members of the/31 subfamily can function in fibronectin matrix assembly (1, 22, 45, 53, 68, 70) .
In contrast to the other/3 chimeras, the/33B chimera was expressed diffusely on the cell surface and did not concentrate in focal adhesions or at sites of association of fibronectin with the plasma membrane, indicating that alternative splicing can regulate integrin distribution by altering intracellular interactions. A protein corresponding to the /33B variant mRNA has not yet been characterized, so the effect of this variant intracellular domain on heterodimer function
is not yet known. However, our results would lead us to predict that heterodimers containing this variant intracellular domain will not concentrate at focal adhesions due to their inability to interact with the appropriate cytoskeletal proteins. Interestingly, a similar splicing variant has been described for the /31 intracellular domain (4), and heterodimers containing a recombinant form of this/31 variant do not concentrate in focal adhesions (6) .
Our results also demonstrate that the/3~ and/33 chimeras can function as dominant negative mutants and inhibit endogenous integrin localization and function. When we compared the levels of expression of the/3~ chimera with the endogenous/3~ subunit, we found that in 15 h assays, the/51 and/33 chimeras could inhibit cell spreading and cell migration when expressed at 1-10 times the level of the endogenous /3~ subunit. Lower levels of expression of the /3~ and /33 chimeras were required to inhibit matrix assembly. Furthermore, lower levels of expression of the chimeric receptors were required to inhibit cell spreading in 1-1.5 h assays as compared to 15 h assays. We also found that/3 intracellular domains differ in their ability to inhibit endogenous integrin function. Higher levels of expression of the/35 chimera were required to inhibit cell spreading as compared to the /3~ and 133 chimeras. This finding is consistent with reported differences in the abilities of endogenous /33 and /35 integrins to function in cell spreading (40) . Furthermore, the/33B chimera did not inhibit endogenous integrin function at any of the expression levels examined.
The ability of the/3~ chimera to inhibit matrix assembly suggests that there is a requirement for the integrin/31 but not the o~5 intracellular domain in matrix assembly in agreement with previous reports (17, 68) . In addition, the /3~ and/33 chimeras always inhibited matrix assembly to a lesser extent than ot5/31 localization to fibrils. This difference may be because the redistribution of ot5/31 and/or its concentration at fibrils requires a stable interaction between the o~5/3m integrin and the cytoskeleton, whereas matrix assembly may require only more transient interactions. In contrast to the /31 and /33 chimeras, the/35 chimera was observed to colocalize with ,5/3~ at fibronectin fibrils, but not to inhibit o~5/3~ localization or function, suggesting that the 135 chimera can bind to cytoplasmic components already concentrated at these sites, but not with sufficient affinity to compete successfully with the/3t intracellular domain for their binding.
The mechanism of inhibition by the chimeric receptors in these processes is not yet known. Inhibition may involve competition with specific integrin-cytoskeletal interactions. However, signal transduction events might also be required to trigger cell spreading, cell migration and matrix assembly. If these events involve integrins, they could also be targets for inhibition. In addition, it is important to note that the proportions of total endogenous integrin receptors that are actually directly involved in any particular biological process such as cell spreading or matrix assembly are likely to be relatively low at any particular time (e.g., 10-20%, as recently reported for interactions of 131 integrins with the dense extracellular matrix of chick embryo fibroblasts; 19). Consequently, the ratio of chimeric molecules to ligandoccupied integrin molecules is probably considerably higher than to total integrin molecules. Furthermore integrin-cytoskeletal interactions required in these processes may be specific for ligand-occupied integrins. Therefore, chimeric receptors may be in excess and competitively inhibiting ligand-occupied integrins rather than the whole population of integrins.
The specific intracellular interactions involved in these processes have not yet been defined. Detailed mutational analysis of the /3~ intracellular domain has defined three regions of the 131 intracellular domain, designated cyto 1, cyto 2, and cyto 3 that are important for/~ integrin localization in focal adhesions (52), although mechanisms responsible for the effects of these mutations are not yet understood. Nonetheless, in vitro binding sites for c~-actinin overlap with these regions (47) and a synthetic peptide overlapping cyto 2 can inhibit the in vitro binding of talin to integrins (64). These results suggest that talin and/or tx-actinin function in receptor localization to focal adhesions consistent with the observations that tx-actinin and talin colocalize with integrins at these sites in tissue culture (reviewed in reference 11). Whether interactions of integrins with ot-actinin and talin are involved in cell spreading, matrix assembly, or cell migration is not yet known. However, rnlcroinjection of antibodies against talin have been found to inhibit both cell spreading and cell migration, implying a role for talin in these two processes (46). Our results also suggest that similar interactions are required for both cell migration and cell spreading, although it is possible that intracellular interactions in addition to those involved in cell spreading are required for cell migration (e.g., see reference 58).
In summary, we found that relatively high levels of expression of the B~ and B3 chimeras could effectively inhibit endogenous integrin function. We also found that some processes were more easily inhibited than others and some B chimeras were better inhibitors than others. If inhibition occurs by the competition of the B chimera for cytoskeletal or cytoplasmic proteins required for function, it is reasonable that some processes would be inhibited more easily than others depending on the intracellular concentration, and possible local concentration, of these components./~ intracellular domains will likely contain overlapping binding sites for several cytoplasmic proteins, each involved in specific integrin-mediated processes. The identity of these proteins, their sites of interaction with/3 intracellular domains and how these interactions are regulated to mediate specific processes are central to understanding integrin intracellular function. Our results define a new approach that allows analysis of integrin intracellular function without complications due to other aspects of heterodimer function. Furthermore, the ability of the different intracellular domains to cross-inhibit each other's function to differing degrees will allow comparisons of integrin intracellular functions.
